|

Associate Attending Physician

Associate Professor of Clinical Medicine

1997 Principal Investigator, Pioglitazone administered daily in patients with non-insulin dependent diabetes and congestive heart failure
1997 Co-Principal Investigator, SCDHeft Trial
1998 Principal Investigator, BG9719 and furosemide in moderate to severe CHF and mild to moderate renal insufficiency
1998- Co-Principal Investigator, UT-15 in patients with pulmonary hypertension
1998 Co-Principal Investigator, Terbogrel in patients with pulmonary hypertension
1999- Principal Investigator INSYNC (Clinical efficacy for cardiac resynchronization in heart failure patients with conduction disease)
1999- Neurohormonal and cytokine modulation in pulmonary hypertension
 
1985-1986 Instructor in Clinical Medicine, College of Physicians & Surgeons, Columbia University, New York, NY
1985-1987 Assistant Physician, Department of Medicine, Columbia University Medical Center, New York, NY
1986-1987 Assistant in Clinical Medicine, College of Physicians & Surgeons, Columbia University, New York, NY
1987-1995 Assistant Attending Physician, Department of Medicine, Columbia University Medical Center, New York, N.Y
1987-1988 Assistant Professor of Clinical Medicine, College of Physicians & Surgeons, Columbia University, New York, NY
1987-1989 Warner-Lambert Assistant Professor of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY
1988-1995 Assistant Professor of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY
1992-Present Director, Cardiology-Obstetrics Liason, Columbia University Medical Center
1993-Present Director, Circulatory Physiology Fellowship Program, Division of Circulatory Physiology, Columbia University Medical Center
1995-Present Associate Professor of Clinical Medicine, College of Physicians & Surgeons, Columbia University, New York, NY
1995-Present Associate Attending Physician, Department of Medicine, Columbia University Medical Center, New York, NY
1997-Present Director of Clinical Services, Heart Failure Center, Division of Circulatory Physiology, Columbia University Medical Center

Horn EM, Kukin ML, Neuberg GW, Goldsmith RL, McCarty M, Gratch M, Medina N, Yushak M, Packer M, Bilezikian JP. Lymphocyte G proteins reflect response to treatment in congestive heart failure. American Heart Journal 1995; 129:98-106.
Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin Marrick L, Schwartz B, Penn J, Medina N, Yushak M, Horn EM, Katz SD, Levin HR, Neuberg GW, DeLong G, Packer M. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995; 92:1499-1506.
Barst RJ, Rubin LJ, Long WA, et al. for the Primary Pulmonary Hypertenstion Study Group. A comparison of continuous intravenous epoprostenol (protacyclin) with conventional therapy for primary pulmonary hypertension.. N Engl J Med 1996; 334: 296-301
Badesch DB, Tapson VF, McGoon MD et al A comparison of continuous intravenous epoprostenol with conventional therapy for pulmonary hypertension secondary to the scleroderma spectrum of disease. Submitted

1981 Associate, American College of Physicians
1981 Diplomate, National Board of Medical Examiners
1983 Diplomate, Board of Internal Medicine
1985 Diplomate, Subspecialty Board of Cardiovascular Disease
1988 Fellow, American College of Cardiology
1989 Member, AHA Basic Science and Clinical Councils
1990 Member, American College of Physicians
1991 Member, The New York Academy of Sciences
1991 Member, AMWA
1992 AHA Council Member Women in Cardiology Committee

1977 Fellow, Hastings Center Institute for Society Life Sciences and Ethics Hastings, NY
1980 Mount Sinai Hadassah Medical Exchange Fellowship
1980 Guttmacher Award Excellence Ob/Gyn
1987 Warner-Lambert Assistant Professor of Medicine
1989 Physician Scientist Award
American College of Chest Physicians

|